Your session is about to expire
← Back to Search
MRI with Gadolinium + Ferumoxytol for Brain Conditions
Study Summary
This trial uses gadolinium and ferumoxytol MRI to diagnose patients with abnormalities in the central nervous system.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 4 trial • 296 Patients • NCT01227616Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am at least 10 years old.I do not have severe brain symptoms like sudden pupil changes, quick muscle weakness, or fast drops in alertness.I have experienced neurological symptoms like headaches or seizures.I do not have genetic hemochromatosis or it has been ruled out with normal TS and SF tests.I have cancer that might be affecting my brain.I can have an MRI scan without needing to be put to sleep.I am using or will use effective birth control during and for two months after the study.I have not taken ferumoxytol in the last 3 weeks.I have abnormal brain scans.
- Group 1: Group I (gadolinium, ferumoxytol, MRI)
- Group 2: Group II (ferumoxytol, gadolinium, MRI)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many test subjects are included in this experiment?
"That is correct. The public clinicaltrials.gov website confirms that this research study, which was first announced on October 6th 2017, is still looking for participants. In total, they need to find 150 individuals willing to take part in the trial at a single location."
Has the United States Food and Drug Administration cleared Ferumoxytol for patient use?
"Ferumoxytol's safety is based on Phase 2 trial data, which indicates that while there are no guarantees of efficacy, the medication is safe to use."
Are we still looking for participants in this clinical trial?
"That is accurate, the public clinicaltrials.gov site says that this research is looking for participants. The listing was first put up on October 6th, 2017 and last updated on June 2nd, 2022. They are hoping to enrol 150 people at a single location."
What other scientific investigations have included Ferumoxytol in their research?
"Currently, there are 27 trials studying the efficacy of Ferumoxytol. 4 of those studies are in Phase 3 and the rest are ongoing. Most of these trials began in Dijon but have since expanded to 69 other locations across Occitanie."
Share this study with friends
Copy Link
Messenger